Ludwig Merker, Thomas Ebert, Martina Guthoff, Berend Isermann
{"title":"糖尿病肾病。","authors":"Ludwig Merker, Thomas Ebert, Martina Guthoff, Berend Isermann","doi":"10.1055/a-1946-3783","DOIUrl":null,"url":null,"abstract":"recommendation 1: Additional information added to the general measures reason: Important measures for the self-management of CKD supporting reference: [11] recommendation 2: Blood pressure target value lowered reason: Current guideline recommendation supporting reference: [12] recommendation 3: Use of non-steroidal mineralocorticoid receptor antagonists in future reason: New data from endpoint studies supporting reference: [13–14] recommendation 4: Use of some SGLT-2 inhibitors also in stage G4 reason: Newer data supporting reference: [11] Preliminary note","PeriodicalId":12241,"journal":{"name":"Experimental and Clinical Endocrinology & Diabetes","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Nephropathy in Diabetes.\",\"authors\":\"Ludwig Merker, Thomas Ebert, Martina Guthoff, Berend Isermann\",\"doi\":\"10.1055/a-1946-3783\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"recommendation 1: Additional information added to the general measures reason: Important measures for the self-management of CKD supporting reference: [11] recommendation 2: Blood pressure target value lowered reason: Current guideline recommendation supporting reference: [12] recommendation 3: Use of non-steroidal mineralocorticoid receptor antagonists in future reason: New data from endpoint studies supporting reference: [13–14] recommendation 4: Use of some SGLT-2 inhibitors also in stage G4 reason: Newer data supporting reference: [11] Preliminary note\",\"PeriodicalId\":12241,\"journal\":{\"name\":\"Experimental and Clinical Endocrinology & Diabetes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and Clinical Endocrinology & Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-1946-3783\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Clinical Endocrinology & Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1946-3783","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
recommendation 1: Additional information added to the general measures reason: Important measures for the self-management of CKD supporting reference: [11] recommendation 2: Blood pressure target value lowered reason: Current guideline recommendation supporting reference: [12] recommendation 3: Use of non-steroidal mineralocorticoid receptor antagonists in future reason: New data from endpoint studies supporting reference: [13–14] recommendation 4: Use of some SGLT-2 inhibitors also in stage G4 reason: Newer data supporting reference: [11] Preliminary note
期刊介绍：
Publishing outstanding articles from all fields of endocrinology and diabetology, from molecular biology to clinical research, this journal is a brilliant resource. Since being published in English in 1983, the popularity of this journal has grown steadily, reflecting the importance of this publication within its field.
Original contributions and short communications appear in each issue along with reviews addressing current topics. In addition, supplementary issues are published each year presenting abstracts or proceedings of national and international scientific meetings.
The journal was initially published in German and is still the oldest endocrinological periodical in the German-language market!
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
